Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Reuss

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Acta Neuropathologica|November 16, 2019
Posterior fossa pilocytic astrocytomas with oligodendroglial features show frequent FGFR1 activation via fusion or mutationPhilipp Sievers, Daniel Schrimpf, Damian Stichel, et al.
Acta Neuropathologica Communications|February 4, 2021
Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activationAndrey Korshunov, Konstantin Okonechnikov, Felix Schmitt-Hoffner, et al.
Gynecologic Oncology|October 11, 2023
Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomasMartin Köbel, Rui Zhe Yang, Eun Young Kang, et al.
Clinical Sarcoma Research|February 28, 2019
Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotypeChristian Koelsche, Damian Stichel, Klaus G Griewank, et al.
Acta Neuropathologica|May 13, 2015
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHODavid E Reuss, Yasin Mamatjan, Daniel Schrimpf, et al.
Histopathology|April 8, 2014
Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumourChristian Koelsche, Leonille Schweizer, Marcus Renner, et al.
Neuro-Oncology|May 5, 2022
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant gliomaMarius Felix, Dennis Friedel, Ashok Kumar Jayavelu, et al.
Acta Neuropathologica|November 28, 2014
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastomaDavid E Reuss, Felix Sahm, Daniel Schrimpf, et al.
Acta Neuropathologica|September 30, 2025
Expansion of the spectrum of tumors diagnosed as myxopapillary ependymomasFuat Kaan Aras, Dennis Friedel, Felix Keller, et al.
Journal of Neuro-Oncology|July 21, 2022
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysisAnna-Luisa Luger, Sven König, Patrick Felix Samp, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Acta Neuropathologica|November 16, 2019
Posterior fossa pilocytic astrocytomas with oligodendroglial features show frequent FGFR1 activation via fusion or mutationPhilipp Sievers, Daniel Schrimpf, Damian Stichel, et al.
Acta Neuropathologica Communications|February 4, 2021
Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activationAndrey Korshunov, Konstantin Okonechnikov, Felix Schmitt-Hoffner, et al.
Gynecologic Oncology|October 11, 2023
Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomasMartin Köbel, Rui Zhe Yang, Eun Young Kang, et al.
Clinical Sarcoma Research|February 28, 2019
Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotypeChristian Koelsche, Damian Stichel, Klaus G Griewank, et al.
Acta Neuropathologica|May 13, 2015
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHODavid E Reuss, Yasin Mamatjan, Daniel Schrimpf, et al.
Histopathology|April 8, 2014
Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumourChristian Koelsche, Leonille Schweizer, Marcus Renner, et al.
Neuro-Oncology|May 5, 2022
HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant gliomaMarius Felix, Dennis Friedel, Ashok Kumar Jayavelu, et al.
Acta Neuropathologica|November 28, 2014
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastomaDavid E Reuss, Felix Sahm, Daniel Schrimpf, et al.
Acta Neuropathologica|September 30, 2025
Expansion of the spectrum of tumors diagnosed as myxopapillary ependymomasFuat Kaan Aras, Dennis Friedel, Felix Keller, et al.
Journal of Neuro-Oncology|July 21, 2022
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysisAnna-Luisa Luger, Sven König, Patrick Felix Samp, et al.
Pageof 8